Annexin Pharmaceuticals Valuation
| ANNX Stock | SEK 0.46 0.01 2.13% |
Annexin Pharmaceuticals is overvalued. Annexin Pharmaceuticals shows a prevailing Real Value of kr0.39 per share. The current price of the firm is kr0.46. Our model approximates the value of Annexin Pharmaceuticals from analyzing the firm fundamentals such as Shares Owned By Insiders of 45.17 %, current valuation of 125.48 M, and Return On Equity of -1.06 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Annexin Pharmaceuticals' price fluctuation is out of control at this time. Calculation of the real value of Annexin Pharmaceuticals is based on 3 months time horizon. Increasing Annexin Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Annexin Pharmaceuticals' intrinsic value may or may not be the same as its current market price of 0.46, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.46 | Real 0.39 | Hype 0.46 | Naive 0.41 |
The intrinsic value of Annexin Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Annexin Pharmaceuticals' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Annexin Pharmaceuticals AB helps investors to forecast how Annexin stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Annexin Pharmaceuticals more accurately as focusing exclusively on Annexin Pharmaceuticals' fundamentals will not take into account other important factors: Annexin Pharmaceuticals Total Value Analysis
Annexin Pharmaceuticals AB is presently anticipated to have takeover price of 125.48 M with market capitalization of 189.95 M, debt of 0, and cash on hands of 22.77 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Annexin Pharmaceuticals fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
125.48 M | 189.95 M | 0 | 22.77 M |
Annexin Pharmaceuticals Asset Utilization
One of the ways to look at asset utilization of Annexin is to check how much profit was generated for every dollar of assets it reports. Annexin Pharmaceuticals AB shows a negative utilization of assets of -0.57 percent, losing kr0.00568 for each kronor of assets held by the firm. Inadequate asset utilization signifies that the company is being less effective with each kronor of assets it shows. Put another way, asset utilization of Annexin Pharmaceuticals AB shows how discouraging it operates for each kronor spent on its assets.Annexin Pharmaceuticals Ownership Allocation
Annexin Pharmaceuticals holds a total of 154.5 Million outstanding shares. Annexin Pharmaceuticals AB retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Annexin Pharmaceuticals Profitability Analysis
Net Loss for the year was (52.14 M) with profit before overhead, payroll, taxes, and interest of 0.About Annexin Pharmaceuticals Valuation
The stock valuation mechanism determines Annexin Pharmaceuticals' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Annexin Pharmaceuticals based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Annexin Pharmaceuticals. We calculate exposure to Annexin Pharmaceuticals's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Annexin Pharmaceuticals's related companies.Annexin Pharmaceuticals AB , a biotechnology company, engages in developing drug candidates for the treatment of various cardiovascular diseases. The company was founded in 2014 and is based in Stockholm, Sweden. Annexin Pharmaceuticals is traded on Stockholm Stock Exchange in Sweden.
8 Steps to conduct Annexin Pharmaceuticals' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Annexin Pharmaceuticals' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Annexin Pharmaceuticals' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Annexin Pharmaceuticals' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Annexin Pharmaceuticals' revenue streams: Identify Annexin Pharmaceuticals' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Annexin Pharmaceuticals' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Annexin Pharmaceuticals' growth potential: Evaluate Annexin Pharmaceuticals' management, business model, and growth potential.
- Determine Annexin Pharmaceuticals' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Annexin Pharmaceuticals' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Annexin Stock Analysis
When running Annexin Pharmaceuticals' price analysis, check to measure Annexin Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Annexin Pharmaceuticals is operating at the current time. Most of Annexin Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Annexin Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Annexin Pharmaceuticals' price. Additionally, you may evaluate how the addition of Annexin Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.